
Sign up to save your podcasts
Or


We discuss the suprachoroidal delivery of a tyrosinase kinase inhibitor and a gene therapy agent for the treatment of neovascular AMD with Dr. Mark Barakat, Assistant Clinical Professor of Ophthalmology, University of Arizona School of Medicine-Phoenix.
By Retina Synthesis4.5
88 ratings
We discuss the suprachoroidal delivery of a tyrosinase kinase inhibitor and a gene therapy agent for the treatment of neovascular AMD with Dr. Mark Barakat, Assistant Clinical Professor of Ophthalmology, University of Arizona School of Medicine-Phoenix.

43 Listeners

18 Listeners

99 Listeners

113,406 Listeners

57,066 Listeners

5 Listeners

9,584 Listeners

12 Listeners

47,911 Listeners

51 Listeners

11 Listeners

466 Listeners

19 Listeners

0 Listeners